BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
22.39
+0.13 (0.58%)
At close: May 28, 2025, 4:00 PM
22.35
-0.04 (-0.18%)
After-hours: May 28, 2025, 4:10 PM EDT
BioLife Solutions Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for BioLife Solutions stock ranges from a low of $27 to a high of $33. The average analyst price target of $30.57 forecasts a 36.53% increase in the stock price over the next year.
Price Target: $30.57 (+36.53%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BioLife Solutions stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 6 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +33.99% | May 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $30 | Strong Buy | Maintains | $27 → $30 | +33.99% | Mar 6, 2025 |
| Northland Capital Markets | Northland Capital Markets | Buy Maintains $28 → $31 | Buy | Maintains | $28 → $31 | +38.45% | Jan 8, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +33.99% | Dec 19, 2024 |
| Keybanc | Keybanc | Buy Maintains $30 → $33 | Buy | Maintains | $30 → $33 | +47.39% | Dec 13, 2024 |
Financial Forecast
Revenue This Year
99.70M
from 82.25M
Increased by 21.21%
Revenue Next Year
117.24M
from 99.70M
Increased by 17.59%
EPS This Year
-0.09
from -0.44
EPS Next Year
0.07
from -0.09
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 103.6M | 126.4M | 151.2M | ||
| Avg | 99.7M | 117.2M | 145.9M | ||
| Low | 95.3M | 109.8M | 139.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.0% | 26.8% | 28.9% | ||
| Avg | 21.2% | 17.6% | 24.5% | ||
| Low | 15.8% | 10.1% | 18.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.06 | 0.13 | 0.53 |
| Avg | -0.09 | 0.07 | 0.51 |
| Low | -0.12 | 0.02 | 0.49 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | 614.9% |
| Avg | - | - | 594.4% |
| Low | - | - | 567.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.